Form 4: TransDigm Director Peter Palmer Acquires Stock Options

TransDigm Group Director Peter Palmer reported the acquisition of 518 stock options with a $1,291.97 exercise price, vesting over five years contingent on performance targets.

Summary

• Peter Palmer, a Director of TransDigm Group INC (TDG), acquired 518 derivative securities in the form of stock options.
• The transaction date for this acquisition was November 4, 2025.
• Each stock option has an exercise price of $1,291.97.
• The options are exercisable at 20% per year over five years, commencing on September 30, 2026.
• Vesting is subject to the achievement of annual operating performance targets in each respective year.
• The options expire on November 4, 2035.
• Following this transaction, Peter Palmer beneficially owns 518 derivative securities directly.
• The filing was signed by Rachel L. Quinlan as attorney-in-fact for Peter Palmer, under a Power of Attorney dated November 6, 2025.

Sentiment

Score: 6

Explanation: Slightly positive. The acquisition of stock options by a director, even if granted, generally signals alignment of interests with shareholders. The performance-based vesting adds a layer of accountability, which is a positive. However, it's not a direct cash investment, which would typically indicate stronger conviction.

Positives

• The acquisition of stock options by a director aligns management's interests with those of shareholders, as the value of the options is tied to the company's stock performance.
• The performance-based vesting schedule incentivizes the director to contribute to the achievement of annual operating targets, potentially driving company growth and profitability.

Negatives

• The vesting of the options is contingent on annual operating performance targets, introducing uncertainty regarding the full realization of the grant.
• This is an option grant, not an open market purchase, meaning there is no direct cash investment by the director at the time of the grant.

Risks

• The stock options are subject to a performance-based vesting schedule, meaning the director may not fully realize the grant if annual operating performance targets are not met.
• The value of the stock options is subject to market fluctuations of TransDigm Group's common stock, potentially impacting the ultimate benefit to the director.
• The exercise price of $1,291.97 is substantial, requiring significant capital or stock appreciation for profitable exercise.

Future Outlook

The future outlook for these options is tied directly to TransDigm Group's ability to meet annual operating performance targets over the next five years, starting September 30, 2026. Successful achievement of these targets will enable the director to vest 20% of the options annually, culminating in full vesting by 2031, assuming all conditions are met.

Management Comments

• The grant of stock options to a director reflects the company's strategy to align executive incentives with long-term shareholder value creation and operational performance.

Industry Context

Performance-based equity grants, such as the stock options detailed in this filing, are a common compensation practice in the aerospace and defense industry. They are designed to incentivize key personnel, including directors, to achieve strategic and financial objectives, thereby aligning their interests with the long-term success of the company and its shareholders. This practice is consistent with broader industry trends in executive compensation.

Comparison to Industry Standards

• Performance-based equity compensation, where vesting is tied to specific operational or financial targets, is a standard practice across the aerospace and defense sector, including companies like Boeing, Raytheon Technologies, and Lockheed Martin, to ensure executive incentives are aligned with company performance.
• The five-year vesting schedule is a typical duration for long-term incentive plans in the industry, promoting sustained focus on strategic goals.
• While specific comparable grants are not detailed in this filing, the structure of this option grant is consistent with common executive compensation frameworks designed to retain talent and drive performance in complex, capital-intensive industries.

Related Party Transactions

• The grant of 518 stock options to Peter Palmer, a Director of TransDigm Group INC, constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potential for increased alignment between director incentives and company performance, which could lead to enhanced shareholder value. There is also potential for future dilution if the options are exercised, though this is a common aspect of equity compensation plans.
• Employees: No direct impact on the broader employee base is indicated by this specific filing.

Next Steps

• The stock options will begin vesting at 20% per year starting September 30, 2026, contingent on the achievement of annual operating performance targets.
• Peter Palmer will continue to file Form 4s for any future changes in beneficial ownership of TransDigm Group securities.

Key Dates

Keywords

TransDigm Group, TDG, Peter Palmer, Stock Options, Director Compensation, Equity Grant, SEC Form 4, Insider Transaction, Performance-Based Vesting, Aerospace & Defense